1. Home
  2. Analysis
  3. Vyepti
  4. Estradiol

Vyepti and Estradiol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vyepti (eptinezumab-jjmr) and Estradiol (estradiol). Common drug interactions include drug ineffective among females.

The phase IV clinical study analyzes what interactions people have when they take Vyepti and Estradiol. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Vyepti?

Vyepti has active ingredients of eptinezumab-jjmr. eHealthMe is studying from 4,897 Vyepti users. Check the latest studies of Vyepti.

What is Estradiol?

Estradiol has active ingredients of estradiol. It is often used in menopause. eHealthMe is studying from 18,986 Estradiol users. Check the latest studies of Estradiol.

On Jul, 19, 2026

21 people who take Vyepti and Estradiol together, and have interactions are studied.

Vyepti and Estradiol drug interactions.

What are the common drug interactions of Vyepti and Estradiol, by gender? *:

female:

  1. Drug ineffective
  2. Nasopharyngitis (inflammation of the nasopharynx)
  3. Thyroid mass
  4. Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
  5. Constipation
  6. Cough
  7. Death
  8. Dementia alzheimer's type (loss of mental ability with alzheimer's symptom)
  9. Functional gastrointestinal disorder (functional problem in separate organs of gastrointestinal system)
  10. Hypersensitivity

male:

n/a

What are the common drug interactions of Vyepti and Estradiol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Drug ineffective
  2. Upper-airway cough syndrome
  3. Blood pressure increased
  4. Hemiparesis (weakness on one side of the body)
  5. Infusion site bruising
  6. Infusion site pain
  7. Thyroid mass
  8. Hypersensitivity
  9. Intervertebral disc protrusion (spinal disc protrusion)

50-59:

  1. Drug ineffective
  2. Migraine (headache)
  3. Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
  4. Death
  5. Headache (pain in head)
  6. Nasopharyngitis (inflammation of the nasopharynx)
  7. Oropharyngeal pain

60+:

  1. Nasopharyngitis (inflammation of the nasopharynx)
  2. Oral herpes (viral infection of mouth)
  3. Blood pressure increased
  4. Constipation
  5. Cough
  6. Dementia alzheimer's type (loss of mental ability with alzheimer's symptom)
  7. Functional gastrointestinal disorder (functional problem in separate organs of gastrointestinal system)
  8. Migraine (headache)
  9. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  10. Throat irritation

What are the existing conditions these people have? *

  1. Migraine (headache): 16 people, 76.19%
  2. Nausea (feeling of having an urge to vomit): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Vyepti and Estradiol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Vyepti and Estradiol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Vyepti:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Estradiol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vyepti and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Estradiol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on eptinezumab-jjmr and estradiol (the active ingredients of Vyepti and Estradiol, respectively), and Vyepti and Estradiol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.